Articles tagged "Outcome"

2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…
2018 American Transplant Congress
Pregnancy Outcomes after Living Liver Donation
G. Lee, E. Sonnenberg, K. Olthoff, D. Goldberg, P. Abt.
Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA; Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Introduction: Women who have previously donated a kidney are at increased risk of pre-eclampsia. Nearly half of living liver donors are women of child-bearing age.…
2018 American Transplant Congress
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients
F. Koraishy,¹ L. Vest,¹ Z. Zhang,¹ M. Schnitzler,¹ V. Dharnidharka,² D. Axelrod,³ R. Ouseph,¹ A. Naik,⁴ N. Lam,⁵ H. Randall,¹ T. Alhamad,² D. Segev,³ D. Brennan,³ B. Kasiske,⁶ G. Hess,⁷ K. Lentine.
¹Saint Louis Univ, St. Louis; ²Washington Univ, St. Louis; ³Lahey Clinic, Burlington; ⁴Univ Michigan, Ann Arbor; ⁵Univ Alberta, Edmonton; ⁶Johns Hopkins, Baltimore; ⁷Hennepin County, Minneapolis; ⁸Symphony Health, Conshohocken.
Recent guidelines support metformin as a therapeutic option in diabetic patients with mild to moderate renal insufficiency. The frequency and outcomes of metformin use in…
2018 American Transplant Congress
Mortality and ESRD in Older Live Kidney Donors with Hypertension
F. Al Ammary,¹ X. Luo,¹ A. Muzaale,¹ A. Massie,¹ D. Brennan,¹ A. Wiseman,² J. Snyder,³ D. Segev.¹
¹Johns Hopkins, Baltimore; ²University of Colorado, Aurora; ³SRTR, Minneapolis.
Hypertension in otherwise healthy screened older kidney donor candidates is viewed as relatively benign, yet the long-term outcome of older donors with hypertension is unclear.…
2018 American Transplant Congress
Prospective Multicenter Validation of Human Transitional B Cell Cytokines as a Predictive Biomarker in Renal Transplantation
A. Cherukuri,¹ D. Chittka,¹ A. Sharma,¹ A. Salama,² C. Magee,² D. Rothstein.¹
¹UPMC, Pittsburgh; ²UCL, London, United Kingdom.
In renal transplantation, non-invasive biomarkers are needed to identify patients at risk for poor outcomes and guide pre-emptive therapy. Here, we assessed B cell cytokines…
2018 American Transplant Congress
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection
N. Goto,¹ M. Minami,¹ K. Futamura,² M. Okada,¹ M. Tsujita,¹ T. Hiramitsu,² S. Narumi,² Y. Watarai.²
¹Nagoya Daini Red Cross Hospital, Transplant Nephrology, Nagoya, Japan; ²Nagoya Daini Red Cross Hospital, Transplant Surgery, Nagoya, Japan.
BackgroundThe human T-lymphotropic virus (HTLV-I), which is endemic in southern Japan, is recognized as the cause of adult T cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy…
2018 American Transplant Congress
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes
L. De Gregorio,¹ E. Bugeaud,¹ G. Galliano,² H. Bohorquez,¹ D. Bruce,¹ I. Carmody,¹ A. Cohen,¹ J. Seal,¹ D. Sonnier,¹ A. Mathur,¹ G. Loss.¹
¹Abdominal Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA; ²Pathology, Ochsner Clinic Foundation, New Orleans, LA.
INTRODUCTIONGraft steatosis is a risk factor for early allograft dysfunction (EAD) and is thought to portend inferior transplant outcomes. The impact of total steatosis, combining…
2018 American Transplant Congress
Addressing the “Crisis” in Pancreas Transplant Volume Using a Multidisciplinary Approach
J. Scalea, S. Bartlett, R. Barth.
Surgery, University of Maryland, Baltimore, MD.
Background: Due in part to the recently revised pancreas allocation system, patients who are listed for simultaneous pancreas and kidney (SPK) transplantation can be transplanted…
2018 American Transplant Congress
The Renal Sparing Protocol after Heart Transplant That Keeps Giving
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, R. Sharoff, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Calcineurin inhibitors (CNI) such as cyclosporine and tacrolimus are known to cause chronic renal failure. As a result, programs have developed renal-sparing protocols (RSP)…
2018 American Transplant Congress
Potential Barriers to Renal Patient Care: Perspectives of Dialysis and Transplant Social Workers
D. Lim,¹ A. Patel,² N. Khoury,² R. Prashar.²
¹Wayne State University School of Medicine, Detroit, MI; ²Department of Nephrology and Transplant Institute, Henry Ford Hospital, Detroit, MI.
Background: Little is studied about social workers' (SW) perceptions and experiences in dialysis and transplant care. We aimed to assess patient care experiences and perspectives…